Coriell Life Sciences

Coriell Life Sciences is using pharmacogenomics to deliver precision medicine. Currently, the safety and efficacy of more than 200 prescription medications are known to be impacted by a patient’s genetics. Pharmacogenomics involves understanding how genes can influence a response to a drug. With people aged 65-69 taking on average 14 prescriptions, Coriell is striving to improve medication efficacy through DNA testing and reduce overall healthcare costs. To attain this, Coriell is using their population-scale Medication Safety Program, Corigen®, which provides actionable solutions informed by genetic knowledge. Coriell works with large employers, health plans, academic institutions and public organizations to develop and improve their precision medicine strategies.

Jobs: